Squamous Cell Carcinoma (SCC) (DBCOND0043488)

Identifiers

Synonyms
Squamous Cell Cancer / Cell Cancer, Squamous / Carcinoma, Squamous Cell / Squamous Cell Cancer (SCC) / Squamous Cell Carcinoma / Carcinoma, Squamous / Squamous Cell Carcinomas / Carcinoma squamous / Carcinomas, Squamous Cell / SCC - Squamous Cell Carcinoma / Squamous Carcinoma / Malignant squamous cell neoplasm (morphologic abnormality) / Planocellular carcinoma / Squamous cell carcinoma (morphologic abnormality) / Squamous cell carcinoma (disorder) / Epidermoid carcinoma / Carcinoma epidermoid

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Bleomycin
A chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03257267
Study of Cemiplimab in Adults With Cervical Cancertreatment3completed
NCT02750033
Intraoperative Margin Assessment During Mohs SurgeryNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00868088
Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the LipNo drug interventionstreatment4completed
NCT06598137
Study to Examine Lesions of the Skin Using Confocal Laser MicroscopyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00559351
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagustreatment3terminated
NCT01358097
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to TherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT00530283
PET-CT for Squamous Cell Carcinoma (SCC) of the Neck Nodes Unknown Primary MalignancyNo drug interventionsNot AvailableNot Availablecompleted
NCT03935893
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancerstreatment2recruiting
NCT05761132
Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Studytreatment2not_yet_recruiting
NCT02376699
Safety Study of SEA-CD40 in Cancer Patientstreatment1terminated
NCT06398418
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid TumorsNo drug interventionstreatment1not_yet_recruiting
NCT01721525
Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)treatment1completed
NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumorstreatment1active_not_recruiting
NCT00661427
Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancertreatment2completed
NCT03370276
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinomatreatment1 / 2active_not_recruiting
NCT01016769
Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)treatment1 / 2completed
NCT01384708
Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancerscreening0completed
NCT00542308
Zalutumumab in Non-curable Patients With SCCHNother2completed
NCT05932511
Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancertreatment0recruiting
NCT00485485
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancertreatment2completed
NCT04391049
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgerytreatment1active_not_recruiting
NCT00363441
A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and NeckNo drug interventionstreatment2 / 3withdrawn
NCT00705016
Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)treatment1 / 2completed
NCT00382031
Zalutumumab in Patients With Non-curable Head and Neck Cancertreatment3completed
NCT00255476
The IRESSA Novel Head and Neck Chemotherapy Evaluation Studytreatment2completed
NCT03509467
Using MC1R Genotype to Impact Melanoma Risk BehaviorNo drug interventionspreventionNot Availablecompleted
NCT00401401
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancertreatment1 / 2terminated
NCT00815295
Study of Sorafenib/Cetuximab in Head and Neck Cancertreatment1 / 2completed
NCT03336606
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanomatreatment1active_not_recruiting
NCT03370406
Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCCtreatment1recruiting
NCT04429542
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients with EGFR-driven Advanced Solid Tumorstreatment1recruiting
NCT05955924
Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trialprevention3recruiting
NCT05970497
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid TumorsNo drug interventionstreatment1recruiting
NCT00632203
Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146)treatment2terminated
NCT04099290
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT02218164
Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinomatreatment2completed
NCT01496521
Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea Polyphenolsprevention3unknown_status
NCT03077243
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCCtreatment2completed
NCT00514943
BIBW 2992 (Afatinib) in Head & Neck Cancertreatment2completed
NCT02666833
Optical Imaging for Preoperative Delineation of Nonmelanoma Skin CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT01129154
Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)treatment2unknown_status
NCT01530997
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Catreatment2completed
NCT06295809
A Study of (Neo)Adjuvant V940 and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)treatment2 / 3recruiting
NCT02229656
Olaparib and Radiotherapy in Head and Neck Cancertreatment1active_not_recruiting
NCT03769285
Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trialprevention2active_not_recruiting
NCT01494415
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancertreatment2unknown_status
NCT00432315
Docetaxel in Non Small Cell Lung Cancer (NSCLC)treatment2completed
NCT00671437
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancertreatment2completed
NCT05845632
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03174275
Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinomatreatment2active_not_recruiting
NCT02442375
Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation ToxicityNo drug interventionstreatment3completed
NCT00673049
Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancertreatment3terminated
NCT00233636
Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Necktreatment2withdrawn
NCT00660218
A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancertreatment1 / 2completed
NCT00188318
Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)No drug interventionstreatment2completed
NCT00185835
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Necktreatment1completed
NCT01491139
Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Necktreatment1withdrawn
NCT01195922
Rapamycin Therapy in Head and Neck Squamous Cell Carcinomatreatment1 / 2completed
NCT00474825
Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and NeckNo drug interventionstreatment1completed
NCT00596830
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histologytreatment3terminated
NCT01345682
LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapytreatment3completed
NCT00240682
Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFRtreatment2completed
NCT00007631
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin CancerNo drug interventionstreatment3completed
NCT00313027
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic CorrelationNo drug interventionsdiagnosticNot Availablecompleted
NCT00412776
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancertreatment2 / 3terminated
NCT00563862
Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)treatmentNot Availableterminated
NCT00011492
Patient Evaluation for Head and Neck Surgery Branch StudiesNo drug interventionsNot AvailableNot Availableterminated
NCT00829192
Phase II AK Study in Organ Transplant Patientsprevention2unknown_status
NCT00448240
Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancertreatment2 / 3terminated
NCT03833167
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)treatment3active_not_recruiting
NCT02916368
The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT02281955
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Studytreatment2active_not_recruiting
NCT00534950
Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and NeckNo drug interventionstreatmentNot Availablecompleted
NCT02549638
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT02285543
A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC PatientsNo drug interventionstreatment2terminated
NCT03321903
EPR Tumor Oximetry With CE India InkNo drug interventionsNot AvailableNot Availableterminated
NCT02310503
Spanish Registry of Mohs SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT00329121
Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situtreatment2completed
NCT00488384
Acitretin Plasma Levels Under Hemodialysisprevention4withdrawn
NCT00038584
A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancertreatment1completed
NCT01728233
Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penistreatment2completed
NCT00190554
A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinomatreatment3terminated
NCT02526953
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patientstreatment3unknown_status
NCT02290145
Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 StageNo drug interventionstreatment2recruiting
NCT04124198
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell CarcinomatreatmentNot Availablerecruiting
NCT00490061
Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapytreatment2terminated
NCT06383728
Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinomatreatment2recruiting
NCT01441128
-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancertreatment1terminated
NCT05252078
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patientstreatment2recruiting
NCT02883556
Study of Pembrolizumab as First Line Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skintreatment2completed
NCT04481256
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapYtreatmentNot Availablerecruiting
NCT02743832
A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.No drug interventionstreatmentNot Availablerecruiting
NCT01175499
Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive TractNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00041613
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving MethotrexateNo drug interventionstreatment3unknown_status
NCT02107235
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancertreatment1completed
NCT02664935
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancertreatment2active_not_recruiting
NCT02045186
Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)No drug interventionsotherNot Availableterminated
NCT00122239
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck CancersNo drug interventionsNot AvailableNot Availableunknown_status
NCT00868725
Detecting Lesions in the Oral Cavity With Thermal ImagingNo drug interventionsNot AvailableNot Availablecompleted
NCT00358930
A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Necktreatment2completed
NCT02285530
GDF15 Based TPF Induction Chemotherapy for OSCC PatientsNo drug interventionstreatment2recruiting
NCT00539630
TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHNtreatment3completed
NCT00041626
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy AloneNo drug interventionstreatment3unknown_status
NCT03906526
A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhibitor in Head and Neck Cancertreatment1terminated
NCT02269020
Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynxNo drug interventionstreatment1completed
NCT00563927
Benefit of Adding Chemotherapy for Advance Nasopharyngeal Carcinoma (T1-4N2-3M0)treatmentNot Availableunknown_status
NCT00389727
Simultaneous Integrated Boost (SIB)- IMRTNo drug interventionstreatment2completed
NCT01362127
Neoadjuvant Chemotherapy Versus Radiochemotherapy for Cancer of the Esophagus or Cardiatreatment2completed
NCT02328391
STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVENo drug interventionsNot AvailableNot Availableunknown_status
NCT06094829
Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral MucosaNo drug interventionsNot AvailableNot Availablecompleted
NCT00368329
Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancertreatment1terminated
NCT04564989
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCCNo drug interventionsNot AvailableNot Availablerecruiting
NCT02254044
Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or EsophagusNo drug interventionstreatment1terminated
NCT00324272
Post-Operative Drainage Following Lymph Node Dissectiontreatment4completed
NCT01142869
An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and NeckNot AvailableNot Availableterminated
NCT02994069
Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markerstreatment2recruiting
NCT00937612
Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor RiskNo drug interventionstreatmentNot Availableterminated
NCT00847912
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trialprevention4completed
NCT03067610
Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancertreatment2completed
NCT00875381
Analysis of Melanocytes (Pigment Cells) in Sun-Exposed SkinNo drug interventionsNot AvailableNot Availablecompleted
NCT00272181
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancertreatment2terminated
NCT02438995
Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Necktreatment1terminated
NCT01104714
Pharmacogenetic Response to Chemotherapy Induction for ORL CancersNo drug interventionsNot AvailableNot Availablecompleted
NCT00073450
Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)No drug interventionstreatment2terminated
NCT02133196
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancertreatment2recruiting
NCT04685798
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CTNo drug interventionsotherNot Availableterminated
NCT05048459
Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of DiseaseNo drug interventionssupportive_careNot Availablerecruiting
NCT05681039
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).treatment2recruiting
NCT05863052
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient PopulationNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06609070
CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCCNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT06615635
Clinical Study Protocol for Cutaneous SCC for Immunocompromised PatientsNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05108090
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and NeckNo drug interventionsscreeningNot Availablerecruiting
NCT04533321
A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinomatreatment2unknown_status
NCT01592721
Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell CarcinomaNo drug interventionstreatment1 / 2completed
NCT01770002
Eversion in Dermatologic Surgery: Is Cosmetic Appearance Improved?No drug interventionssupportive_careNot Availablecompleted
NCT00507702
Identification of Key Blood Molecular Markers for ImmunotherapyNo drug interventionsNot AvailableNot Availableterminated
NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancerstreatment1 / 2recruiting
NCT00201279
Chemoprevention Study of Oral Cavity Squamous Cell CarcinomaNo drug interventionsprevention3completed
NCT05987579
Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the ScalpNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02426879
Esophagectomy for Patients With Esophageal Cancer and Cervical Lymph Node MetastasesNo drug interventionstreatmentNot Availablecompleted
NCT05340543
Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)No drug interventionsNot AvailableNot Availableunknown_status
NCT04370587
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumorstreatment1 / 2recruiting
NCT03652233
Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Necktreatment1withdrawn
NCT01773447
Set-back Suture Versus Traditional Vertical Mattress SutureNo drug interventionssupportive_careNot Availablecompleted
NCT05929547
Patient Perspectives in Squamous Cell Carcinoma Clinical TrialsNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01794845
Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinomatreatment2terminated
NCT01161498
Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancertreatment3terminated
NCT00400205
Study of Induction Docetaxel, Cisplatin and 5-Fluorouraciltreatment2terminated
NCT03791905
PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinomatreatment2unknown_status
NCT01020097
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxNo drug interventionsdiagnosticNot Availablecompleted
NCT03381183
IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinomatreatment1active_not_recruiting
NCT03015883
Alpha Radiation Emitters Device for the Treatment of Squamous Cell CarcinomaNo drug interventionstreatmentNot Availablecompleted
NCT00443261
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Necktreatment1terminated
NCT02352428
Skin Cancer Screening Education StudyNo drug interventionsscreeningNot Availableunknown_status
NCT03387111
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressedtreatment1 / 2terminated
NCT00770393
Laryngeal Preservation in Pyriform Sinus CarcinomaNo drug interventionstreatment2 / 3completed
NCT00765193
The Impact of Total Body Skin Examination on Skin Cancer DetectionNo drug interventionsdiagnosticNot Availablecompleted
NCT05610293
T1 Squamous Cell Carcinomas of the LipNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00011778
PS-341 and Radiation to Treat Advanced Cancer of the Head and Necktreatment1completed
NCT03486509
Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinomatreatment2unknown_status
NCT03636685
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLCtreatment1 / 2unknown_status
NCT00601185
Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo.No drug interventionsNot AvailableNot Availablecompleted
NCT00364715
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00581815
Spectroscopy With Surface Coils and DecouplingNo drug interventionsdiagnostic1completed
NCT01127737
Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant RecipientsNo drug interventionsscreeningNot Availablecompleted
NCT03786237
Rigosertib for RDEB-SCCtreatment1 / 2recruiting
NCT02776137
Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Necktreatment2completed
NCT02394652
The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trialtreatment2completed
NCT02819752
PEmbrolizumab Combined With Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neckother1terminated
NCT04475952
Early Diagnosis of Upper Digestive Tract DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT02059252
Safety, Tolerability and Performance of SmartMatrix Dermal Replacement ScaffoldNo drug interventionstreatment1 / 2terminated
NCT04150900
1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Necktreatment2active_not_recruiting
NCT02223975
Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval DiseaseNo drug interventionsNot AvailableNot Availablesuspended
NCT03985670
Teripalimab Plus Chemotherapy in Local Advanced Esophageal CancerNo drug interventionstreatment2unknown_status
NCT03162042
Role of Myostatin, Activin A and Follistatin Cachexia of ENT CancersNo drug interventionsNot AvailableNot Availablecompleted
NCT04889742
Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent TumorsNo drug interventionstreatment2not_yet_recruiting
NCT01077999
Chemoradiation and Panitumumab for Esophageal Cancertreatment2completed
NCT00195299
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & NeckNot AvailableNot Availablecompleted
NCT01016899
Electronic Brachytherapy for the Treatment of NMSCNo drug interventionsNot AvailableNot Availablecompleted
NCT02151149
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderlytreatment4completed
NCT03237013
Strategies to Promote Skin HealthNo drug interventionspreventionNot Availablecompleted
NCT03729518
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the NeckNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04969419
Incidence of Melanoma and Non-melanoma Skin Cancer in People With VitiligoNo drug interventionsNot AvailableNot Availablecompleted
NCT03708224
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Necktreatment2recruiting
NCT06384924
Raman Spectroscopy and Skin CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03462524
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary PhysiologyNo drug interventionsNot AvailableNot Availablecompleted
NCT02580916
Utility of the Skin Cancer Quality of Life Impact ToolNo drug interventionshealth_services_researchNot Availablecompleted
NCT03802058
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancertreatment2terminated
NCT06377735
BAI-BACE for Advanced Lung Squamous Cell CarcinomaNo drug interventionstreatmentNot Availablerecruiting
NCT05019235
Study of the Association Between Tumor Microenvironment Macrophages and Treatment Response in Squamous Cell Carcinoma of the Anal CanalNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05337163
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in ChinaNo drug interventionsNot AvailableNot Availablecompleted
NCT01526486
Videoscopic Versus Open Inguinal Lymphadenectomy for CancerNo drug interventionstreatmentNot Availablecompleted
NCT04738786
Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue CancersNo drug interventionstreatmentNot Availablerecruiting
NCT05729139
Cemiplimab/Peg-Interferon-α in Advanced CSCCtreatment1withdrawn
NCT02902822
Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoNo drug interventionsdiagnosticNot Availablecompleted
NCT03494322
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancertreatment2active_not_recruiting
NCT06046625
Needs and Preferences of Patients With Head-neck Cutaneous SCCNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05854030
Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous CarcinomaNo drug interventionsNot AvailableNot Availablerecruiting
NCT00139230
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Necktreatment2completed
NCT04681248
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsNot AvailableNot Availableavailable
NCT00547157
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Necktreatment2completed
NCT01363466
Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical CancerNo drug interventionstreatment3terminated
NCT04410874
Imvamune Vaccine for the Treatment of Non-melanoma Skin Cancertreatment1 / 2terminated
NCT04260074
Epigenetic Changes in Head and Neck CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05126173
DERM US and EU Validation StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05941676
Prognostic Immune Biomarkers in HNSCCNo drug interventionsNot AvailableNot Availablecompleted
NCT00476476
Erlotinib in Women With Squamous Cell Carcinoma of the Vulvartreatment2completed
NCT03115476
A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalpprevention3terminated
NCT06450080
Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the TongueNo drug interventionsotherNot Availablerecruiting
NCT00046189
Cancer Risk in Carriers of the Gene for Xeroderma PigmentosumNo drug interventionsNot AvailableNot Availablecompleted
NCT02943044
Quantitative Optical Sensor Findings in Head & Neck Squamous Cell CarcinomaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00586040
Photochemical Tissue BondingNo drug interventionstreatment2completed
NCT01298167
Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT00176267
Paclitaxel, Carboplatin And Low Dose Radiation As Induction Therapy In Locally Advanced Head And Neck Cancertreatment2completed
NCT01586767
Intensity-Modulated or Proton Radiation Therapy for Sinonasal MalignancyNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03579004
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancertreatment2unknown_status
NCT05648604
Mentored Community Gardening for Individuals With Skin CancerNo drug interventionsotherNot Availableactive_not_recruiting
NCT02890368
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoidestreatment1terminated
NCT01976468
Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"No drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01484769
Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity CellsNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00446446
PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)treatment2completed
NCT05065346
Neoadjuvant DaRT for Locally Advanced Oral Cavity SCCNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT02095912
Aggressive Squamous Cell Carcinoma in Organ Transplant RecipientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03215810
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancertreatment1completed
NCT05974410
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsNot AvailableNot Availableavailable
NCT03758781
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumorstreatment1completed
NCT01540695
Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E HistologyNo drug interventionsNot AvailableNot Availablecompleted
NCT02298595
Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinomatreatment1 / 2withdrawn
NCT00578214
Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic SurgerytreatmentNot Availablecompleted
NCT05535023
Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinomatreatment2withdrawn
NCT01135823
Symptom Assessment With Patient SurveysNo drug interventionsNot AvailableNot Availablecompleted
NCT00038038
Assessment of Head and Neck Tumor Hypoxia Using 18F-FluoromisonidazoleNo drug interventionsdiagnosticNot Availablewithdrawn
NCT00751543
The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation TherapyNo drug interventionstreatmentNot Availableunknown_status
NCT00139243
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Necktreatment1 / 2completed
NCT01456143
Optical Imaging of Head and Neck CancerNo drug interventionstreatmentNot Availableterminated
NCT01089803
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01009203
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinomatreatment2terminated
NCT00001603
The Effects of Upper Airway and Digestive Tract Tumors on the Immune SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT02370303
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT05070403
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinomatreatment2recruiting
NCT02410603
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01115790
A Phase 1 Study in Participants With Advanced Cancertreatment1completed
NCT04201002
Surgery Plus Intraoperative Radiotherapy as Treatment for Squamous Cell Carcinoma Over Pilonidal Disease.No drug interventionsNot AvailableNot Availablecompleted
NCT06041802
A Study of MK-3475A (Pembrolizumab Formulated With MK-5180) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)No drug interventionstreatment2recruiting
NCT00427102
MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Necktreatment1terminated
NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasistreatment1 / 2recruiting
NCT02213133
Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomastreatment2terminated
NCT05027633
Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)treatment2recruiting
NCT00176254
Paclitaxel, Carboplatin and Radiotherapy as Induction Therapy in Locally Advanced Head and Neck Cancertreatment2completed
NCT05125354
A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRTNo drug interventionsNot AvailableNot Availablecompleted
NCT02013154
A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumabtreatment1completed
NCT04814953
HRQoL Keratinocyte CarcinomasNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT03641547
M6620 Plus Standard Treatment in Oesophageal and Other Cancertreatment1completed
NCT00073398
Vaccine Treatment for Advanced Non-Small Cell Lung CancerNo drug interventionstreatment1 / 2completed
NCT02131805
Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell CarcinomaNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT04714983
DNX-2440 for Resectable Colorectal Liver MetastasisNo drug interventionstreatment1suspended
NCT01208883
A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck CancerNo drug interventionstreatment1completed
NCT00201383
Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patientstreatment3completed
NCT01043328
Human Papillomavirus on Oral Tissue, Saliva and SerumNo drug interventionsNot AvailableNot Availablecompleted
NCT02409628
EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision WoundsNo drug interventionstreatmentNot Availablecompleted
NCT03714828
Study of TVEC in Patients With Cutaneous Squamous Cell CancerNo drug interventionstreatment2completed
NCT03769311
Cetuximab in Head and Neck Cancer Patientstreatment2completed
NCT01760811
CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENTtreatment1 / 2unknown_status
NCT03342378
PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT02586207
Pembrolizumab in Combination With CRT for LA-SCCHNtreatment1active_not_recruiting
NCT05883007
Dose Optimized BNCT for Head and Neck CancerNo drug interventionstreatment1active_not_recruiting
NCT00605709
Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinomatreatment2withdrawn
NCT01561456
Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lungtreatment2completed
NCT03952585
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancertreatment2 / 3suspended
NCT02088515
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinomatreatment4completed
NCT03944915
De-Escalation Therapy for Human Papillomavirus Negative Diseasetreatment2recruiting
NCT05061537
Study of PF-07263689 in Participants With Selected Advanced Solid Tumorstreatment1terminated
NCT03854032
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Necktreatment2terminated
NCT05843032
3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin AssessmentNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01333852
Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancertreatment2terminated
NCT03221400
PEN-866 in Patients With Advanced Solid Malignanciestreatment1 / 2unknown_status
NCT00937300
T-cell Based Immunotherapy for Head and Neck Cancertreatment1withdrawn
NCT00472459
PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-melanoma Skin CancerNo drug interventionsprevention3completed
NCT03875859
Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)treatment2terminated
NCT00001442
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancertreatment1completed
NCT00836342
Correlation Between Skin Carotenoid Levels and Previous History of Skin CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04808999
Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)treatment2active_not_recruiting
NCT02128906
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Designtreatment2recruiting
NCT04628806
Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor CellsNo drug interventionsNot AvailableNot Availableunknown_status
NCT04688749
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin DamageNo drug interventionsNot AvailableNot Availableterminated
NCT00895349
Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)No drug interventionsdiagnosticNot Availablecompleted
NCT05007613
Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinomatreatment2unknown_status
NCT03837613
Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.No drug interventionsNot AvailableNot Availableunknown_status
NCT00596219
Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell CarcinomatreatmentNot Availablecompleted
NCT05104619
Spectroscopic Analysis of Tongue Tumor Samples.No drug interventionsNot AvailableNot Availablerecruiting
NCT03458117
T-VEC in Non-melanoma Skin CancerNo drug interventionstreatment1completed
NCT01077817
Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)Not AvailableNot Availablecompleted
NCT03719924
Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinomatreatment2active_not_recruiting
NCT03284424
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)treatment2completed
NCT03025724
Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in SitutreatmentNot Availableunknown_status
NCT05693116
Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal VestibuleNo drug interventionsNot AvailableNot Availablerecruiting
NCT06227416
Skin Tumor Biomarkers by Mass Spectrometry ImagingNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT06418516
Early Detection of Esophageal Squamous Cancer With the Capsule Sponge DeviceNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)No drug interventionsNot AvailableNot Availableunknown_status
NCT03292822
Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Linetreatment1completed
NCT01872130
Reflectance Confocal Microscopy of Wounds During Moh's Surgery: Feasibility Testing of a Mosaicing Algorithm for Intraoperative Imaging of Cancer MarginsNo drug interventionsNot AvailableNot Availablecompleted
NCT03476330
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemiaprevention2active_not_recruiting
NCT03092830
Molecular Characterization of Cutaneous TumorsNo drug interventionsNot AvailableNot Availableunknown_status
NCT05038657
Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC).treatment2recruiting
NCT01631357
Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancertreatment2 / 3completed
NCT04442126
A Study of NM21-1480 in Adult Patients With Advanced Solid TumorsNo drug interventionstreatment1 / 2terminated
NCT03742726
Study Assessing the Safety and Performance of Smart Matrix®No drug interventionstreatmentNot Availableunknown_status
NCT00540566
Optical Biopsy of Human Skin in Conjunction With Laser TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT05852665
Buccal Cancer Resection Ultrasound GuidedNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01133665
Cetuximab and Lenalidomide in Head and Necktreatment2completed
NCT00409565
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancertreatment2completed
NCT06137274
Pilot Trial of Adaptive Radiotherapy Boost for HNSCCNo drug interventionstreatmentNot Availablerecruiting
NCT03190174
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancerstreatment1 / 2completed
NCT01232374
Nimotuzumab in Combination With Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinomatreatment2unknown_status
NCT05740774
Surgical Margin Assessment by 3D UltrasoundNo drug interventionsdiagnosticNot Availablerecruiting
NCT00884520
An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037Not Available0completed
NCT00101582
Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancertreatment3completed
NCT01148082
School Response to Families Who Have Children With CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT00573131
Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancertreatment2terminated
NCT04839731
Combination 5-FU / Calcipotriene Cream for SCCIS/SCCtreatment0recruiting
NCT01666431
Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatmenttreatment2terminated
NCT05202860
Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients With Actinic KeratosisNo drug interventionstreatment2active_not_recruiting
NCT00500760
Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancertreatment2completed
NCT01905891
Nanocytology Test to Evaluate Skin Cancer in High Risk PatientsNo drug interventionshealth_services_researchNot Availablecompleted
NCT00374062
Effect of the Subconscious on Mohs Micrographic SurgeryNo drug interventionstreatmentNot Availablecompleted
NCT00662662
Sexual Behavior in Head and Neck Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT03223662
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision TherapyNo drug interventionstreatment2terminated
NCT00426062
Free Radical Level in SCC of Tongue Patients Tumor, Serum and SalivaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00652080
An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)treatment1 / 2completed
NCT05858229
Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.No drug interventionstreatment1 / 2recruiting
NCT04224389
IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell CarcinomasNo drug interventionsNot AvailableNot Availablerecruiting
NCT03058289
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6treatment1 / 2completed
NCT00574392
Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-VivoNo drug interventionsNot AvailableNot Availablecompleted
NCT00197444
Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancertreatment2completed
NCT04606940
Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)No drug interventionsNot AvailableNot Availablecompleted
NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapyNo drug interventionsNot AvailableNot Availableterminated
NCT05574101
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancertreatment2recruiting
NCT01265472
Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic MalignancyNo drug interventionsNot AvailableNot Availableunknown_status
NCT00966472
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLCtreatment1completed
NCT00793169
Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic SurgeryNo drug interventionsNot AvailableNot Availablecompleted
NCT05402046
Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsmsNo drug interventionsdiagnosticNot Availableunknown_status
NCT04099446
A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin CancerNo drug interventionsNot AvailableNot Availablewithdrawn
NCT03982212
A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumorstreatment1active_not_recruiting
NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumorstreatment1completed
NCT04595981
Chemo-embolization for Head and Neck Cancertreatment2not_yet_recruiting
NCT00878995
Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinomasupportive_care1completed
NCT02985255
Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tonguetreatment2unknown_status
NCT00707655
Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapytreatment1 / 2terminated
NCT04922450
Clinical Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy for Operable Locally Advanced Head and Neck Squamous Cell Carcinomatreatment2unknown_status
NCT01755650
Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of MalignanciesNo drug interventionsdiagnostic0terminated
NCT01211938
Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive TractNo drug interventionstreatment2 / 3completed
NCT04435938
A Study of SBRT for Squamous Cell Carcinoma of the Head and NeckNo drug interventionstreatment2unknown_status
NCT00704041
Four Doses of MAGE Vaccine for Patients With Squamous Cell Carcinoma of the Head and Necktreatment1unknown_status
NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumorstreatment1active_not_recruiting
NCT05964101
Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinomatreatment2recruiting
NCT01445405
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancertreatment1completed
NCT00591149
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancertreatment2terminated
NCT01497041
A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatmenttreatment2unknown_status
NCT06215612
ctDNA and MRI Parameters in Head and Neck CancerNo drug interventionsbasic_scienceNot Availablenot_yet_recruiting
NCT04266327
RISI in the Treatment of Recurrent Metastatic SCC of Thoracic Inlet Lymph NodesNo drug interventionstreatmentNot Availablerecruiting
NCT01532453
Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted PatientsNo drug interventionsprevention3terminated
NCT01706939
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancertreatment3active_not_recruiting
NCT05482880
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck RegionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04142489
In Vivo Damage Induced bu UV in the Epidermis of the ScalpNo drug interventionsotherNot Availablecompleted
NCT00797732
A Pilot Study of Acupuncture Treatment for DysphagiaNo drug interventionssupportive_careNot Availablecompleted
NCT05329792
L19IL2/L19TNF in Skin Cancer Patientstreatment2recruiting
NCT06479070
Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.No drug interventionsotherNot Availablenot_yet_recruiting
NCT05859074
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancertreatment1active_not_recruiting
NCT02817958
Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penistreatment2recruiting
NCT02379039
Multimodal Monitoring of Radiotherapy Response in Squamous Cell CancerNo drug interventionsNot AvailableNot Availablecompleted